Los 10 mejores artículos 2016 de neurología NEJM

Top 10 Neurology Articles of 2016: NEJM Journal Watch Editors’ Picks

Information sourced from NEJM Journal Watch:

NEJM Journal Watch Neurology Top Stories of 2016

S. Andrew Josephson, MD

A perspective on the most important research in the field from the past year

Dear Readers,

I am pleased to introduce this year’s NEJM Journal Watch Neurology Top Stories of 2016. As in years past, I have made these selections after carefully reviewing all of the year’s summaries. In making the choices, I have tried to strike a balance between relevance to the clinician, coverage of the various fields within neurology, recognition of landmark studies, and media publicity and public awareness. The sequence of stories is not intended to reflect their relative importance. I hope you find the list useful and thought-provoking.

The NEJM Journal Watch Neurology Top Stories of 2016, in no particular order, are:

Surgical Decompression for Degenerative Cervical Myelopathy

Meta-Analysis Supports Benefit of Endovascular Stroke Therapy

Does Stopping Donepezil for Alzheimer Disease Increase Nursing Home Placement?

Cerebral Cavernous Malformations: Which Ones Should We Worry About?

Phase 2 Trial of Rivastigmine for Fall Prevention in Parkinson Patients

Ten-Year Stroke Risk Is Comparable After Carotid Stenting or Endarterectomy

Treatment of Convulsive Status Epilepticus: Evidence-Based Guidelines

What Is the Relapse Risk in Acute Disseminated Encephalomyelitis?

Thymectomy for Myasthenia Gravis

Calcium Supplements Linked to Dementia Risk in Women with Cerebrovascular Disease

Best wishes for a happy and productive 2017.

NEJM Journal Watch is produced by NEJM Group, a division of the Massachusetts Medical Society. Copyright ©2017 Massachusetts Medical Society. All rights reserved.

The above message comes from NEJM Journal Watch, who is solely responsible for its content.

You have received this email because you requested follow-up information to an Epocrates DocAlert® message. For more information about Epocrates, please click here.

For questions, feedback, or suggestions regarding Epocrates DocAlert® messages, please contact the Medical Information Team at docalert@epocrates.com.

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *